v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES              
Net loss $ (16,520,000) $ (1,430,000) $ (17,581,000) $ (5,512,000) $ (17,950,000) $ (23,092,000)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation and amortization expense         134,000 0  
Amortization of operating right of use assets         204,000 0  
Stock-based compensation         290,000 79,000  
Common stock issued in exchange for services         972,000 150,000  
Provision (recovery) for expected credit losses         53,000 0  
Change in fair value of warrant liabilities 9,784,000   6,414,000   6,246,000 3,518,000  
Change in fair value of convertible promissory notes         0 6,530,000  
Loss on convertible note conversions 0   1,874,000   0 3,467,000  
Loss on issuance of registered direct Common Stock         0 729,000  
Loss on Consideration Shares and Warrants         0 1,277,000  
Income from equity method investments (3,000)   0   (5,000) 0 $ (35,000)
Expense for debt issuance costs due to fair value election on Anson Notes         0 350,000  
Changes in operating assets and liabilities:              
Prepaid expense and other assets         (1,392,000) 187,000  
Account receivable         (98,000) 0  
Accounts payable         (1,124,000) (501,000)  
Operating lease liabilities         (200,000) 0  
Accrued expense and other liabilities         (300,000) (202,000)  
Net cash used in operating activities         (13,170,000) (7,508,000)  
CASH FLOWS FROM INVESTING ACTIVITIES              
Purchase of Property and equipment         (897,000) 0  
Net cash used in investing activities         (897,000) 0  
CASH FLOWS FROM FINANCING ACTIVITIES              
Repayment of insurance note         (50,000) (394,000)  
Expense for debt issuance costs due to fair value election on Anson Notes         0 (350,000)  
Proceeds from issuance of insurance loan         462,000 452,000  
Proceeds from Anson convertible notes, net of OID         0 5,000,000  
Net cash provided by financing activities         32,956,000 8,975,000  
Net increase in cash and cash equivalents         18,889,000 1,467,000  
Cash and cash equivalents at beginning of period   $ 7,797,000   $ 1,443,000 7,797,000 1,443,000 1,443,000
Cash and cash equivalents at end of period 26,686,000   2,910,000   26,686,000 2,910,000 $ 7,797,000
Supplemental disclosure of cash flow information:              
Cash paid for interest         0 0  
Cash paid for taxes         0 0  
Non-cash investing and financing activities:              
New right of use asset and lease liability         403,000 0  
Amortization of deferred offering costs to additional paid-in capital         89,000 92,000  
Conversion of Principal and Interest Into Common Stock [Member]              
Non-cash investing and financing activities:              
Issuance of Common Stock as principal and interest repayment for convertible notes         0 5,456,000  
Consideration Warrants [Member]              
CASH FLOWS FROM FINANCING ACTIVITIES              
Proceeds from issuance of Common Stock and warrants, net of issuance costs         0 3,255,000  
ATM Offering [Member]              
CASH FLOWS FROM FINANCING ACTIVITIES              
Proceeds from issuance of Common Stock, net of issuance costs $ 8,400,000   $ 1,000,000   11,828,000 1,012,000  
Underwritten Public Offering [Member]              
CASH FLOWS FROM FINANCING ACTIVITIES              
Proceeds from issuance of Common Stock, net of issuance costs         $ 20,716,000 $ 0